| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.7 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |